loading page

Transcriptome changes during peanut oral immunotherapy and omalizumab treatment
  • +13
  • Sofia Bjorkander,
  • Simon Kebede Merid,
  • David Brodin,
  • Josef Brandstrom,
  • Fredrik Fagerstrom-billai,
  • Marieke van der Heiden,
  • Jon Konradsen,
  • Michael Kabesch,
  • Cornelis Drunen,
  • Korneliusz Golebski,
  • Anke-Hilse Maitland - van der Zee,
  • Uros Potocnik,
  • Susanne Vijverberg,
  • Anna Nopp,
  • Caroline Nilsson,
  • Erik Melén
Sofia Bjorkander
Karolinska Institute

Corresponding Author:[email protected]

Author Profile
Simon Kebede Merid
Karolinska Institute
Author Profile
David Brodin
Karolinska Institute
Author Profile
Josef Brandstrom
Karolinska Institute
Author Profile
Fredrik Fagerstrom-billai
Karolinska Institute
Author Profile
Marieke van der Heiden
University Medical Centre Groningen
Author Profile
Jon Konradsen
Astrid Lindgren Children's Hospital
Author Profile
Michael Kabesch
University of Regensburg
Author Profile
Cornelis Drunen
University of Amsterdam
Author Profile
Korneliusz Golebski
University of Amsterdam
Author Profile
Anke-Hilse Maitland - van der Zee
Amsterdam University Medical Centres
Author Profile
Uros Potocnik
University of Maribor
Author Profile
Susanne Vijverberg
Amsterdam University Medical Centres
Author Profile
Anna Nopp
Karolinska Institute
Author Profile
Caroline Nilsson
Karolinska Institute
Author Profile
Erik Melén
Karolinska Institute
Author Profile
30 Jun 2021Submitted to Pediatric Allergy and Immunology
07 Jul 2021Reviewer(s) Assigned
21 Jul 2021Review(s) Completed, Editorial Evaluation Pending
27 Jul 2021Editorial Decision: Revise Major
20 Sep 20211st Revision Received
21 Sep 2021Review(s) Completed, Editorial Evaluation Pending
21 Sep 2021Reviewer(s) Assigned
13 Oct 2021Editorial Decision: Accept
Jan 2022Published in Pediatric Allergy and Immunology volume 33 issue 1. 10.1111/pai.13682